F. Hammerschmidt, J. P. Quinn et al.
1.04 ppm (m, 21H; 3 ꢃ iPr); 13C NMR (100.65 MHz, CDCl3): d=72.9 (d,
J=162.9 Hz), 68.3 (d, J=5.9 Hz), 62.6 (d, J=6.6 Hz), 62.3 (d, J=6.6 Hz),
21.5 (d, J=5.9 Hz), 18.11 (3C), 18.02 (3C), 16.5 (d, J=5.8 Hz, 2C),
12.7 ppm (3C); 31P NMR (161.98 MHz, CDCl3): d=22.2 ppm; IR (Si):
n˜ =3303, 2943, 2867, 1465, 1275, 1258, 1054, 1029, 971 cmÀ1; elemental
analysis calcd (%) for C16H37O5PSi (368.52): C 52.15, H 10.12; found: C
52.43, H 10.10.
66.5 (dd, J=36.9, 2.9 Hz; CHCP), 63.3 (d, J=6.8 Hz), 62.6 (d, J=
6.8 Hz), 19.1 (d, J=10.7 Hz; CH3), 16.42 (d, J=4.9 Hz; CH3), 16.39 ppm
(d, J=5.8 Hz; CH3); 31P NMR (161.98 MHz, CDCl3): d=24.8 ppm (d,
J=158.5 Hz; 13CHP); MS (FID): m/z (%): 213 [M+] (2.5), 214 (100).
A
1,2-dihydroxy-[1-13C1]propylphosphonic acid ((Æ)-3 and (Æ)-[1-13C1]3):
(Æ)-3:
1
(Æ)-10: H NMR (400.27 MHz, CDCl3): d=4.30 (qdd, J=6.3, 5.8, 2.8 Hz,
(Æ)-11 (0.368 g, 1.73 mmol), allylTMS (0.985 g, 1.38 mL, 8.65 mmol,
5 equiv), and bromotrimethylsilane (3.337 g, 2.88 mL, 21.8 mmol) in dry
1,2-C2H4Cl2 (8.0 mL) was kept under argon for 16 h at room temperature.
Volatile components were then removed in vacuo (0.50 mbar, ambient to
408C) and the residue was dissolved in a 1:1 mixture of EtOH/H2O
(10 mL). The solvent was removed under reduced pressure and the resi-
due was taken up in water (10 mL) and concentrated NH3 (1.0 mL) and
then lyophilized to leave a gummy residue of the ammonium salt of (Æ)-
3 (0.30 g, containing an unknown amount of ammonia and water; the
yield was assumed to be 95%). The spectroscopic data (1 H, 13C, and 31P)
were identical to those of the ammonium salt of the (1R,2R)-dihydroxy-
propylphosphonic acid derived from fosfomycin. If desired, the ammoni-
um salt can be purified by the method used for the conversion of the cy-
clohexylammonium salt of 1,2-dihydroxypropylphosphonic acid to the
ammonium salt.[10]
1H; PCCH), 4.21–4.10 (m, 4H; 2 ꢃ OCH2), 4.01 (dd, J=10.8, 2.8 Hz,
1H; PCH), 2.35 (brs, 1H; OH), 1.32 (d, J=6.3 Hz, 3H; CH3), 1.31 (t, J=
7.1 Hz, 6H; 2 ꢃ OCCH3), 1.10–1.00 ppm (m, 21H; 3 ꢃ iPr); 13C NMR
(100.65 MHz, CDCl3): d=72.9 (d, J=167.9 Hz), 68.6 (d, J=9.0 Hz), 62.7
(d, J=7.0 Hz), 62.3 (d, J=6.0 Hz), 18.4 (erroneously reported[10] to be a
doublet at 17.7), 18.3 (3C), 18.2 (3C), 16.67 (d, J=5.9 Hz), 16.64 (d, J=
5.9 Hz), 12.5 ppm (3C); 31P NMR (161.98 MHz, CDCl3): d=21.0 ppm;
IR (Si): n˜ =3306, 2943, 2867, 1465, 1242, 1258, 1141, 1096, 1054, 1028,
972 cmÀ1
;
HRMS (ESI): m/z: calcd for C16H37O5PSiNa [M+Na]+:
391.2046; found: 391.2052.
(Æ)-[1-13C1]9 and (Æ)-[1-13C1]10: In analogy to the preparation of the un-
labeled species, (Æ)-2-(triisopropylsilyloxy)propane-[1-13C1]nitrile ((Æ)-
[1-13C1]8), 1.60 g, 7.0 mmol) was converted into the crude aldehyde
(1.37 g), which was immediately transformed into labeled hydroxy-
phosphonates (Æ)-[1-13C1]9 (1.242 g, 48%, based on the starting nitrile)
and (Æ)-[1-13C1]10 (0.155 g, 6%, containing 16 mol% diethyl phosphite),
both with 99% 13C at C-1.
(Æ)-[1-13C1]3·
(NH3)x: The labeled 1,2-dihydroxypropylphosphonate (Æ)-
E
[1-13C1]11 (0.337 g, 1.59 mmol) was converted into the ammonium salt of
(Æ)-[1-13C1]3 following the procedure used for the unlabeled species.
1H NMR (400.13 MHz, D2O): d=4.05 (m, 1H; CHCP), 3.50 (ddd, J=
138.0, 9.5, 4.5 Hz, 1H; 13CHP), 1.31 ppm (t, J=5.5 Hz, 3H; CH3);
13C NMR (100.61 MHz, D2O): d=73.3 (d, J=141.5 Hz; 13CHP), 68.3 (d,
J=39.8 Hz; CCP), 18.8 ppm (d, J=8.4 Hz; CH3); 31P NMR (161.97 MHz,
D2O): d=17.0 ppm (d, J=141.7 Hz).
(Æ)-
ACHTUNGTRENNUNG
[1-13C1]9: 1H NMR (400.13 MHz, CDCl3): d=4.30 (m, 1H; CHCP),
4.15 (sext, J=7.0 Hz, 4H; 2 ꢃ OCH2), 3.59 (td, J=142.6, 6.0 Hz, 1H;
13CHP), 2.78 (brs, 1H; OH), 1.35 (t, J=6.0 Hz, 3H), 1.31 (t, J=7.0 Hz,
3H; OCCH3), 1.30 (t, J=7.0 Hz, 3H; OCCH3), 1.18–1.00 ppm (m, 21H;
3
ꢃ
iPr); 13C NMR (100.61 MHz, CDCl3): d=72.8 (d, J=162.3 Hz;
13CHP), 68.3 (dd, J=37.9, 5.8 Hz; C13CP), 62.6 (d, J=6.8 Hz; OCH2),
62.2 (d, J=6.8 Hz; OCH2), 21.4 (dd, J=5.8, 1.9 Hz; CH3), 18.09 and
18.00 (2s, 6C), 16.4 (d, J=5.8 Hz, 2C), 12.7 ppm (3C); IR (Si): n˜ =3303,
2-Methyl-2-propenyl 4-nitrobenzoate and 2-methyl-2-[1-13C1]propenyl 4-
nitrobenzoate (17 and [1-13C1]17): A solution of isopropenylmagnesium
bromide (0.5m in THF, 20 mL, 10.0 mmol) was added to a suspension of
paraformaldehyde (0.150 g, 5.0 mmol) in dry Et2O (2 mL) at À208C
under argon. The mixture was stirred overnight at room temperature.
After careful addition of H2O (10 mL) and dissolution of the precipitate
with dilute H2SO4, the organic phase was separated and the aqueous
phase was extracted with CH2Cl2 (2ꢃ10 mL). The combined organic solu-
tions were dried (Na2SO4) and filtered (the Na2SO4 was washed with dry
CH2Cl2), and most of the CH2Cl2 was distilled off at atmospheric pressure
over a short column. The resulting THF solution of the alcohol was
stirred at room temperature under argon for 30 min with molecular
sieves (3.5 g, 4 ꢄ). The mixture was then cooled to 08C, whereupon 4-ni-
trobenzoyl chloride (1.45 g, 7.81 mmol), dry pyridine (2.6 mL), and
DMAP (52 mg) were successively added. After stirring overnight at
room temperature, the solution was decanted from the molecular sieves
(which were rinsed with CH2Cl2), and the combined solutions were treat-
ed with H2O (30 mL) and concentrated HCl (about 4.5 mL, to dissolve
the precipitate). The organic layer was separated and the aqueous phase
was extracted twice with CH2Cl2. The combined organic phases were
dried (MgSO4) and concentrated under reduced pressure. The residue
was purified by flash chromatography (hexane/CH2Cl2, 1:1, Rf =0.50 for
hexane/EtOAc, 10:1; 0.55 for hexane/CH2Cl2, 1:1) to yield 4-nitroben-
zoate 17 (0.686 g, 62%) as yellowish crystals; m.p. 68–708C (hexane/a
few drops of 1,2-C2H4Cl2; lit.:[21] no data). (400.13 MHz, CDCl3): d=8.25
(AA’BB’ system, 4H; Har), 5.07 (brs, 1H; =CH), 5.00 (brs, 1H; =CH),
4.77 (brs, 2H; OCH2), 1.83 ppm (brs, 3H; CH3); (100.61 MHz, CDCl3):
d=164.33, 150.59, 139.31, 135.56, 130.72 (2C), 123.56 (2C), 113.76, 69.03,
19.55 ppm; IR (ATR): n˜ =3117, 1710, 1520, 1268, 1119 cmÀ1; elemental
analysis calcd (%) for C11H11NO4 (221.2): C 59.73, H 5.01, N 6.33; found:
C 59.85, H 4.79, N 6.28.
2943, 2867, 1465, 1275, 1258, 1054, 1029, 971 cmÀ1
(Æ)-
.
ACHTUNGTRENNUNG
[1-13C1]10: 1H NMR (400.13 MHz, CDCl3): d=4.30 (m, 1H; CHCP),
4.21–4.10 (m, 4H; 2 ꢃ OCH2), 4.01 (ddd, J=140.5, 10.5, 3.0 Hz, 1H;
13CHP), 2.55 (brs, 1H; OH), 1.32 (d, J=7.0 Hz, 3H; CH3), 1.31 (t, J=
7.0 Hz, 6H; 2 ꢃ OCCH3), 1.12–0.98 ppm (m, 21H; 3 ꢃ iPr); 13C NMR
(100.61 MHz, CDCl3): d=72.9 (d, J=161.7 Hz; 13CHP), 68.6 (dd, J=
37.9, 9.3 Hz; CCP), 62.7 (d, J=6.9 Hz), 62.3 (d, J=6.1 Hz), 18.1, 18.02,
and 17.98 (2s, 6C), 16.42 (d, J=5.4 Hz), 16.40 (d, J=5.4 Hz), 12.3 ppm
(3C); 31P NMR (161.98 MHz, CDCl3): d=22.3 ppm (d, J=161.7 Hz;
13CHP); MS (FID): m/z (%): 369 [M+] (1), 370 (100).
A
(Æ)-diethyl 1,2-dihydroxy-[1-13C1]propylphosphonate ((Æ)-11 and (Æ)-
[1-13C1]11): A solution of TIPS-protected diol (Æ)-9 (0.654 g, 1.77 mmol)
in dry CH3CN (15 mL), water (7 drops), and HF (40%, 10 drops) was
left at room temperature in a small plastic bottle until the starting mate-
rial had been consumed (22 h) and then concentrated under reduced
pressure in a round-bottomed glass flask. The residue was flash-chroma-
tographed (EtOAc/MeOH, 20:1, Rf =0.14) to give diol (Æ)-11 (0.368 g,
98%) as a viscous oil. 1H NMR (400.27 MHz, CDCl3): d=4.27–4.08 (m,
5H; 2 ꢃ OCH2, PCCH), 3.65 (brt, J=6.5 Hz, 1H; CHP), 3.35–3.00 (two
broad overlapping s, 2H; OH), 1.34 (t, J=7.0 Hz, 3H; CH3), 1.33 (t, J=
7.0 Hz, 3H; CH3), 1.29 ppm (dd, J=6.2, 1.5 Hz, 3H; CH3); 13C NMR
(100.65 MHz, CDCl3): d=71.4 (d, J=159.1 Hz), 66.4, 63.46 (d, J=
7.3 Hz), 62.49 (d, J=7.3 Hz), 19.0 (d, J=11.7 Hz), 16.47 (d, J=5.1 Hz),
16.44 ppm (d, J=5.1 Hz); 31P NMR (162.03 MHz, CDCl3): d=23.3 ppm;
IR (Si): n˜ =3317, 2979, 2940, 2867, 1462, 1391, 1275, 1053, 1029, 971 cmÀ1
;
elemental analysis calcd (%) for C7H17O5P (212.18): C 39.62, H 8.08;
found: C 39.47, H 7.83.
Similarly, 13C-labeled paraformaldehyde (0.162 g, 5.23 mmol) gave
(Æ)-[1-13C1]11: Similarly, TIPS-protected diol (Æ)-[1-13C1]9 (1.12 g,
3.03 mmol) was converted into diol (Æ)-[1-13C1]11 (0.592 g, 92%).
1H NMR (400.13 MHz, CDCl3): d=4.16 (m, 5H; 2 ꢃ OCH2, PCCH),
3.90 (ddd, J=9.0, 2.5, 2.0 Hz, 1H; OH), 3.64 (tdd, J=142.0, 9.0, 3.0 Hz,
1H; 13CHP), 3.54 (d, J=4.5 Hz, 1H; OH), 1.32 (t, J=7.0 Hz, 3H; CH3),
1.31 (t, J=7.0 Hz, 3H; CH3), 1.27 ppm (ddd, J=5.0, 4.5, 1.5 Hz, 3H;
CH3); 13C NMR (100.61 MHz, CDCl3): d=71.8 (d, J=159.4 Hz; 13CHP),
[1-13C1]17 (0.789 g, 68%), 99% C-13 labeled, m.p. 62–638C (hexane).
1
N
Har), 5.06 (d, J=6.8 Hz, 1H; =CH), 4.99 (d, J=12.13 Hz, 1H; =CH), 4.76
(d, J=147.8 Hz, 2H; O13CH2), 1.82 ppm (d, J=4.29 Hz, 3H; Me);
13C NMR (100.61 MHz, CDCl3): d=164.33 (d, J=2.3 Hz; CO), 150.59
(Car), 139.30 (d, J=46.0 Hz; C=), 135.56 (Car), 130.73 (2 ꢃ CHar), 123.56
13346
ꢂ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2011, 17, 13341 – 13348